What medicine is zolgensma?
Zolgensma is an AAV gene drug, which is used to treat spinal muscular atrophy (sma). Previously, the drug "Noxisodium", which is also used to treat spinal muscular atrophy, dropped from 700,000 yuan to nearly 10,000 yuan, which attracted many people's attention. The two drugs belong to the same disease. The biggest difference is that they are made by different manufacturers. Nosina sodium injection was developed by Biogen Idec Ltd and was first approved in the United States on February 23, 20 16. Zolgensma was developed by a company of Novartis.
Who is the manufacturer of Zolgensma?
Novartis Group is a multinational company in the global medical and health industry. Headquartered in Basel, Switzerland, its business covers more than 50 countries and regions in the world. Covering innovative patented drugs, eye care, generic drugs, consumer health care, vaccines and diagnostics, it is in a leading position in the world in all fields.
The above is the introduction of what kind of medicine zolgensma is, and the price of this medicine is also very expensive. More information about zolgensma is shared on this website.